Bank of New York Mellon
CHTP

Bank of New York Mellon’s CHELSEA THERAPEUTICS INT'L LTD CHTP Stock Holding History

Bank of New York Mellon’s Portfolio CHTP Stock Details CHTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-543,123
Closed -$3M – 4311
2014
Q1 		$3M Buy
543,123
+221,053
+69% +$1.11M ﹤0.01% 2607
2013
Q4 		$1.43M Buy
322,070
+7,198
+2% +$24.3K ﹤0.01% 3091
2013
Q3 		$942K Buy
314,872
+39,990
+15% +$115K ﹤0.01% 3276
2013
Q2 		$633K Buy
+274,882
New +$556K ﹤0.01% 3407

Other funds holding CHTP

Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return

Bank of New York Mellon's CHTP Position: Q2 2014 in Review

Bank of New York Mellon sold out of CHELSEA THERAPEUTICS INT'L LTD (CHTP) in Q2 2014, closing a stake of 543,123 shares — an estimated $3M sold.

Bank of New York Mellon first reported a position in CHTP in Q2 2013 and held it in 4 quarters. The position peaked at $3M in Q1 2014. 6 funds tracked by Wall St. Rank hold CHTP as of Q2 2014.

  • Bank of New York Mellon reported no remaining CHELSEA THERAPEUTICS INT'L LTD position as of Q2 2014 after selling out during the quarter.
  • Bank of New York Mellon sold 543,123 CHELSEA THERAPEUTICS INT'L LTD shares in Q2 2014, an estimated $3M.
  • Bank of New York Mellon first reported a position in CHELSEA THERAPEUTICS INT'L LTD in Q2 2013 and held it in 4 quarters.
  • Bank of New York Mellon's CHELSEA THERAPEUTICS INT'L LTD position peaked at $3M in Q1 2014.
  • 6 funds tracked by Wall St. Rank held CHELSEA THERAPEUTICS INT'L LTD as of Q2 2014.

Based on Bank of New York Mellon's 13F filing for Q2 2014, filed 12 Aug 2014.